miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib

BIOMED RESEARCH INTERNATIONAL

Merhautova, J; Hezova, R; Poprach, A; Kovarikova, A; Radova, L; Svoboda, M; Vyzula, R; Demlova, R; Slaby, O, 2015: miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib. BIOMED RESEARCH INTERNATIONAL , doi: 10.1155/2015/941980

Research Groups:

CEITEC authors: